BEUDAMED
    72 results · 19ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé RX Carotid Stent System; Protégé GPS Self-Expanding Peripheral Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé RX Carotid Stent System; Protégé GPS Self-expanding Peripheral Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé™ RX Carotid Stent System, Protégé™ GPS™ Self-Expanding Peripheral Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé™ RX Carotid Stent System, tégé™ GPS™ Self-Expanding Peripheral Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé GPS Self-Expanding Peripheral Stent System, Protégé RX Carotid Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé RX Self-expanding Stent System, Protégé GPS Self-Expanding Peripheral Stent System

    Stent, Carotid

    FDA Pre-Market Approval
    FDA Class 3 ·Protégé™ GPS™ Self-Expanding Peripheral Stent System, and Protégé™ RX Carotid Stent System

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 pharmDx

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 PharmDx

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 pharmDx

    Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

    FDA classification
    FDA Class 3 ·Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 pharmDx

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN(R)

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN®

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN(R)

    Acid, Hyaluronic, Intraarticular

    FDA Pre-Market Approval
    FDA Class 3 ·HYALGAN